BlackRock Japan’s Teva Pharmaceuticals TEVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$47M Buy
+1,297,628
New +$51.8M 0.16% 151
2016
Q3
Sell
-9,760
Closed -$490K 1415
2016
Q2
$490K Sell
9,760
-1,637
-14% -$87.1K ﹤0.01% 723
2016
Q1
$610K Sell
11,397
-307,148
-96% -$18M ﹤0.01% 735
2015
Q4
$20.9M Buy
318,545
+26,569
+9% +$1.64M 0.08% 286
2015
Q3
$16.5M Buy
291,976
+48,310
+20% +$3.13M 0.07% 324
2015
Q2
$14.4M Sell
243,666
-109,690
-31% -$6.77M 0.06% 387
2015
Q1
$22M Buy
353,356
+22,380
+7% +$1.3M 0.09% 264
2014
Q4
$19M Buy
330,976
+7,585
+2% +$423K 0.07% 308
2014
Q3
$17.4M Buy
323,391
+11,944
+4% +$633K 0.08% 293
2014
Q2
$16.3M Buy
311,447
+58,494
+23% +$2.99M 0.07% 298
2014
Q1
$13.4M Buy
252,953
+235,753
+1,371% +$10.9M 0.06% 372
2013
Q4
$689K Buy
17,200
+7,000
+69% +$276K ﹤0.01% 742
2013
Q3
$385K Buy
10,200
+2,500
+32% +$97.5K ﹤0.01% 780
2013
Q2
$302K Buy
+7,700
New +$300K ﹤0.01% 798

Other funds holding TEVA